Arquivamento - Art. 36 §1° da LPI
#11.2
10/01/2024
RPI 2804
Application data
Number
112022008029Type
Filing
Publication
PCT
US2020057659 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 10/01/2024. We update with every new RPI gazette, published weekly.
Applicants
ALUCENT BIOMEDICAL, INC.
US
Inventors
K. W. (pessoa física)
US
IPC Classification
Priority claims
US
62/927,430 · 10/29/2019
Abstract
FORMULAÇÕES DE NAFTALIMIDA DIMÉRICA. A presente divulgação fornece novas formulações para naftalimidas diméricas e estudos de estabilidade das mesmas. Em algumas modalidades, a naftalimida dimérica é um sal diacetato do Composto de Fórmula (I).
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
10/01/2024
RPI 2804
#6.23
06/18/2024
RPI 2789
#1.3
07/12/2022
RPI 2688
#1.1
05/10/2022
RPI 2679
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.